TY  - JOUR

T1  - Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluation.

JO  - Health Technol Assess

PY  - 2004/04/01

AU  - Czoski-Murray C

AU  - Warren E

AU  - Chilcott J

AU  - Beverley C

AU  - Psyllaki MA

AU  - Cowan J

ED  - 

DO  - DOI: 10.3310/hta8130

VL  - 8

IS  - 13

SP  - iii

EP  - 91

Y2  - 2024/12/22

ER  -